An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity.

Antibody-Dependent Cell Cytotoxicity CD4 Antigens / metabolism CD4-Positive T-Lymphocytes / virology Cells, Cultured HIV Antibodies / immunology HIV-1 / immunology Humans Protein Binding Protein Conformation env Gene Products, Human Immunodeficiency Virus / chemistry
17b A32 ADCC CD4i Abs HIV-1 State 2A cryo-EM envelope glycoproteins smFRET

Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
10 Apr 2019
Historique:
received: 23 08 2018
revised: 03 12 2018
accepted: 28 02 2019
entrez: 12 4 2019
pubmed: 12 4 2019
medline: 22 11 2019
Statut: ppublish

Résumé

The HIV-1 envelope glycoprotein (Env) (gp120-gp41)

Identifiants

DOI: 10.1016/j.chom.2019.03.002 PMID: 30974085 PMC: PMC6592637
pubmed: 30974085
pii: S1931-3128(19)30114-3
doi: 10.1016/j.chom.2019.03.002
pmc: PMC6592637
mid: NIHMS1532406
pii:
doi:

Substances chimiques

CD4 Antigens 0
HIV Antibodies 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

578-587.e5

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129769
Pays : United States
Organisme : NIGMS NIH HHS
ID : P01 GM056550
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124982
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI122953
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116274
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIAID NIH HHS
ID : K22 AI116262
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5036-41
pubmed: 15051887
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Exp Med. 2005 May 2;201(9):1407-19
pubmed: 15867093
J Virol. 2006 Jan;80(2):835-44
pubmed: 16378985
Biochemistry. 2006 Sep 12;45(36):10973-80
pubmed: 16953583
Clin Immunol. 2007 Jul;124(1):57-68
pubmed: 17521962
Nature. 2008 Sep 4;455(7209):109-13
pubmed: 18668044
J Infect Dis. 2009 Apr 1;199(7):1007-18
pubmed: 19231994
J Virol. 2009 Nov;83(21):10892-907
pubmed: 19692465
J Virol. 2010 Feb;84(3):1439-52
pubmed: 19939925
Mol Cell. 2010 Mar 12;37(5):656-67
pubmed: 20227370
J Struct Biol. 2010 Jun;170(3):427-38
pubmed: 20338243
Blood. 2011 Jan 6;117(1):145-55
pubmed: 20870901
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87
pubmed: 21158699
J Virol. 2011 Jun;85(12):5949-60
pubmed: 21471235
J Med Chem. 2012 May 10;55(9):4382-96
pubmed: 22497421
J Virol. 2013 Feb;87(3):1884-9
pubmed: 23175369
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E69-78
pubmed: 23237851
J Virol. 2014 Mar;88(5):2633-44
pubmed: 24352444
J Virol Methods. 2014 Nov;208:107-14
pubmed: 25125129
J Virol. 2014 Nov;88(21):12895-906
pubmed: 25165110
J Vis Exp. 2014 Sep 14;(91):51995
pubmed: 25286159
Science. 2014 Nov 7;346(6210):759-63
pubmed: 25298114
J Virol. 2015 Jan;89(1):545-51
pubmed: 25339767
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94
pubmed: 25941367
J Virol. 2015 Dec 04;90(4):2127-34
pubmed: 26637462
J Virol. 2015 Dec 30;90(6):2993-3002
pubmed: 26719277
Nat Methods. 2016 Apr;13(4):341-4
pubmed: 26878382
ACS Med Chem Lett. 2016 Jan 19;7(3):330-4
pubmed: 26985324
Structure. 2016 May 3;24(5):697-709
pubmed: 27041594
J Struct Biol. 2016 Jul;195(1):93-9
pubmed: 27108186
J Virol. 2016 Jun 10;90(13):6127-6139
pubmed: 27122574
EBioMedicine. 2016 Oct;12:208-218
pubmed: 27633463
MBio. 2016 Oct 25;7(5):
pubmed: 27795397
Sci Rep. 2016 Nov 09;6:36685
pubmed: 27827447
Elife. 2016 Nov 15;5:
pubmed: 27845625
J Virol. 2017 Jan 18;91(3):
pubmed: 27881646
J Virol. 2017 Feb 14;91(5):
pubmed: 28003492
J Virol. 2017 Mar 13;91(7):
pubmed: 28100618
J Virol. 2017 May 12;91(11):
pubmed: 28331088
Structure. 2017 Nov 7;25(11):1719-1731.e4
pubmed: 29056481
Virology. 2018 Feb;515:38-45
pubmed: 29248757
MBio. 2018 Mar 20;9(2):
pubmed: 29559570
Elife. 2018 Mar 21;7:
pubmed: 29561264
J Virol. 2018 Jun 13;92(13):
pubmed: 29669829
Cell. 2018 Aug 9;174(4):926-937.e12
pubmed: 29961575
J Struct Biol. 2018 Nov;204(2):329-337
pubmed: 30145327
J Virol. 2019 Jan 17;93(3):
pubmed: 30429344
J Virol. 1998 Oct;72(10):7992-8001
pubmed: 9733838

Auteurs

Nirmin Alsahafi (N)

Centre de Recherche du CHUM, Montreal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.

Nordine Bakouche (N)

Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.

Mohsen Kazemi (M)

Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.

Jonathan Richard (J)

Centre de Recherche du CHUM, Montreal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.

Shilei Ding (S)

Centre de Recherche du CHUM, Montreal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.

Sudipta Bhattacharyya (S)

Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.

Durba Das (D)

Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.

Sai Priya Anand (SP)

Centre de Recherche du CHUM, Montreal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.

Jérémie Prévost (J)

Centre de Recherche du CHUM, Montreal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.

William D Tolbert (WD)

Infectious Diseases Division, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Hong Lu (H)

Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.

Halima Medjahed (H)

Centre de Recherche du CHUM, Montreal, QC, Canada.

Gabrielle Gendron-Lepage (G)

Centre de Recherche du CHUM, Montreal, QC, Canada.

Gloria Gabrielle Ortega Delgado (GG)

Centre de Recherche du CHUM, Montreal, QC, Canada.

Sharon Kirk (S)

Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

Bruno Melillo (B)

Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

Walther Mothes (W)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06536, USA.

Joseph Sodroski (J)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Amos B Smith (AB)

Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

Daniel E Kaufmann (DE)

Centre de Recherche du CHUM, Montreal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada; Department of Medicine, Université de Montréal, Montreal, QC, Canada; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.

Xueling Wu (X)

Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.

Marzena Pazgier (M)

Infectious Diseases Division, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Isabelle Rouiller (I)

Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia. Electronic address: isabelle.rouiller@unimelb.edu.au.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montreal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada. Electronic address: andres.finzi@umontreal.ca.

James B Munro (JB)

Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA. Electronic address: james.munro@tufts.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes du système immunitaire › Cytotoxicité immunologique › Cytotoxicité à médiation cellulaire dépendante des anticorps › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Antigènes CD4 › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD4+ › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Cellules › Cellules cultivées › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antiviraux › Anticorps antideltarétrovirus › Anticorps anti-VIH › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › VIH-1 (Virus de l'Immunodéficience Humaine de type 1) › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Métabolisme › Liaison aux protéines › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Conformation moléculaire › Conformation des protéines › An Asymmetric Opening of HIV-1 Envelope...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales structurales › Protéines de l'enveloppe virale › Produits du gène env › Produits du gène env du virus de l'immunodéficience humaine › An Asymmetric Opening of HIV-1 Envelope...